These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8114845)

  • 1. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Hirsh J
    N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Lotke PA; Ecker ML
    N Engl J Med; 1994 Mar; 330(12):863. PubMed ID: 8114846
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
    Hauch O; Khattar SC; Jørgensen LN
    Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apropos of the assessment of "prophylaxis of deep vein thrombosis in orthopedic surgery"].
    Boutin B
    J Chir (Paris); 1994 May; 131(5):277-8. PubMed ID: 7989420
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 9. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Koch A; Bouges S; Ziegler S; Dinkel H; Daures JP; Victor N
    Br J Surg; 1997 Jun; 84(6):750-9. PubMed ID: 9189079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the patient with deep vein thrombosis.
    Weismantel D
    J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
    Samama MM
    Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical administration of unfractionated and low molecular weight heparin for prevention of appositional thrombus formation].
    Koppenhagen K; Häring R; Proksch W; Erdmann K; Leick M; Bundrock P; Franke J
    Vasa Suppl; 1992; 35():99-100. PubMed ID: 1336219
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary prophylaxis with low molecular weight heparin: the dose?
    Horne MK
    Thromb Haemost; 2001 Oct; 86(4):1129. PubMed ID: 11686343
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
    Forbes CD
    Br J Clin Pract; 1989 Nov; 43(11):396-400. PubMed ID: 2558702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.